Community Contributor
Member since 2025
Views
1.7k Total number of views
Fair Values Set
27 Total number of fair values set
Comments
0 Total number of comments
Followers
3 Total number of followers

Former Silicon Valley Biotech Venture Capitalist

No link added
US$39.99
49.9% undervalued intrinsic discount
Fair Value
Profit Margin
21.21%
Future PE
29.38x
Price in 2030
US$55.82
ELTX logo
Elicio Therapeutics

Very Bullish

98% of pancreatic cancer patients in Phase II study generated powerful immune responses to the KRAS antigens. Median T-cell immune response above threshold was 44-fold.Read more

View narrative
US$100
90.4% undervalued intrinsic discount
Fair Value
Profit Margin
21.21%
Future PE
29.38x
Price in 2031
US$140.1